During the current grant period, CCSG developmental funds were used to support the mission of the Cancer Center in 2 categories critical to the advancement of its goals: 1) additional faculty recruitment in disciplines related to the strategic vision of the Center and 2) pilot project grants to stimulate cross-disciplinary research involving population science. Both categories have proven rich opportunities for the Center to strengthen and diversify its research portfolio. Funds requested to support faculty recruitment in strategic areas have enabled the Center to attract top talent by providing a start-up/transition package that has enabled 8 new recruits to have the resources to immediately develop their research programs. Since their arrival at MSK, these 8 investigators have received $23.8M in peer-reviewed funding and produced over 25 manuscripts from their laboratories. Funds requested to support cross-disciplinary pilot projects involving PSR and other Center programs supported 16 projects, covering the broad spectrum of areas of population research that characterize the PSR Program, with multiple awards in each of PSR?s major programmatic themes: 1) cancer etiology and risk; 2) health behavior and symptom control; and 3) health care delivery, access and disparities. The projects were multidisciplinary as a requirement, and in many cases creative cross-disciplinary interactions were formed, matching population scientists with basic laboratory investigators or clinical investigators. Results have been exciting, with 3 of our junior investigators receiving their first NIH grants as a result of the pilot funds provided by this program. To date, 8 peer-reviewed grants have been awarded stemming from the research conducted in these pilot projects (4 NCI, 2 other NIH, 2 ACS). The total direct cost from these grants is $8,816,229. Building on the success in the current grant period, the Center proposes to continue its program in PSR Pilot Project Funding. We also propose a second faculty recruitment initiative to support the recruitment and integration of faculty with expertise in computational biology. This initiative will build on recent, strategic infrastructure investments in computational biology made by MSK.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-55
Application #
10084840
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-20
Project End
2023-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
55
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Meyer, Jan-Philip; Tully, Kathryn M; Jackson, James et al. (2018) Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers. Bioconjug Chem 29:538-545
McFarland, Daniel C; Shaffer, Kelly; Breitbart, William et al. (2018) C-reactive protein and its association with depression in patients receiving treatment for metastatic lung cancer. Cancer :
Lacouture, Mario E; Anadkat, Milan; Jatoi, Aminah et al. (2018) Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review. Clin Colorectal Cancer 17:85-96
Blumenthal, Gideon M; Bunn Jr, Paul A; Chaft, Jamie E et al. (2018) Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer. J Thorac Oncol 13:1818-1831
Shaffer, Kelly M; Nelson, Christian J; DuHamel, Katherine N (2018) Barriers to participation in a sexual health intervention for men following treatment for rectal and anal cancer. Psychooncology 27:1082-1085
Park, Kay J; Patel, Prusha; Linkov, Irina et al. (2018) Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy. Histopathology 72:766-776
Pianko, Matthew J; Goldberg, Aaron D; Lesokhin, Alexander M (2018) Clinical Development of PD-1 Blockade in Hematologic Malignancies. Cancer J 24:31-35
Navi, Babak B; Marshall, Randolph S; Bobrow, Dylan et al. (2018) Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke: The TEACH Pilot Randomized Clinical Trial. JAMA Neurol 75:379-381
Shah, Sona; Boucai, Laura (2018) Effect of Age on Response to Therapy and Mortality in Patients With Thyroid Cancer at High Risk of Recurrence. J Clin Endocrinol Metab 103:689-697
Goldman, Debra A; Hovinga, Koos; Reiner, Anne S et al. (2018) The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis. J Neurosurg :1-9

Showing the most recent 10 out of 8799 publications